Scientists at Johns Hopkins University School of Medicine and Academia Sinica in Taiwan have developed an experimental RNA-based treatment that prevents brain damage and improves learning, memory and social behavior in mice carrying a rare genetic mutation associated with autism spectrum disorder and intellectual disability.